214 related articles for article (PubMed ID: 10958084)
1. Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats.
Wadenberg ML; Kapur S; Soliman A; Jones C; Vaccarino F
Psychopharmacology (Berl); 2000 Jul; 150(4):422-9. PubMed ID: 10958084
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of antipsychotic-like effects by combined treatment with the alpha1-adrenoceptor antagonist prazosin and the dopamine D2 receptor antagonist raclopride in rats.
Wadenberg ML; Hertel P; Fernholm R; Hygge Blakeman K; Ahlenius S; Svensson TH
J Neural Transm (Vienna); 2000; 107(10):1229-38. PubMed ID: 11129112
[TBL] [Abstract][Full Text] [Related]
3. Antagonism at 5-HT(2A) receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats.
Wadenberg MG; Browning JL; Young KA; Hicks PB
Pharmacol Biochem Behav; 2001 Mar; 68(3):363-70. PubMed ID: 11325387
[TBL] [Abstract][Full Text] [Related]
4. Using pharmacokinetic-pharmacodynamic modelling as a tool for prediction of therapeutic effective plasma levels of antipsychotics.
Olsen CK; Brennum LT; Kreilgaard M
Eur J Pharmacol; 2008 Apr; 584(2-3):318-27. PubMed ID: 18325493
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the effects of α2 adrenoceptor antagonism with the D2 receptor antagonist raclopride on conditioned avoidance responding in rats.
Jacobson SM; Prus AJ
Behav Pharmacol; 2010 Oct; 21(7):654-9. PubMed ID: 20729715
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D(2) receptor occupancy is a common mechanism underlying animal models of antipsychotics and their clinical effects.
Wadenberg ML; Soliman A; VanderSpek SC; Kapur S
Neuropsychopharmacology; 2001 Nov; 25(5):633-41. PubMed ID: 11682246
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of antipsychotic-like properties of the dopamine D2 receptor antagonist, raclopride, by the additional treatment with the 5-HT2 receptor blocking agent, ritanserin, in the rat.
Wadenberg ML; Salmi P; Jimenez P; Svensson T; Ahlenius S
Eur Neuropsychopharmacol; 1996 Nov; 6(4):305-10. PubMed ID: 8985714
[TBL] [Abstract][Full Text] [Related]
8. Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models.
Natesan S; Reckless GE; Nobrega JN; Fletcher PJ; Kapur S
Neuropsychopharmacology; 2006 Sep; 31(9):1854-63. PubMed ID: 16319908
[TBL] [Abstract][Full Text] [Related]
9. Atropine acts in the ventral striatum to reduce raclopride-induced catalepsy.
Alcock SJ; Hemsley KM; Crocker AD
Eur J Pharmacol; 2001 Jul; 424(3):179-87. PubMed ID: 11672560
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsy.
Wadenberg ML; Ahlenius S
J Neural Transm Gen Sect; 1991; 83(1-2):43-53. PubMed ID: 1673344
[TBL] [Abstract][Full Text] [Related]
11. Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride.
Yokoi F; Gründer G; Biziere K; Stephane M; Dogan AS; Dannals RF; Ravert H; Suri A; Bramer S; Wong DF
Neuropsychopharmacology; 2002 Aug; 27(2):248-59. PubMed ID: 12093598
[TBL] [Abstract][Full Text] [Related]
12. Adjunctive galantamine, but not donepezil, enhances the antipsychotic-like effect of raclopride in rats.
Wiker C; Schilström B; Sandbäck C; Wadenberg ML; Svensson TH
Int J Neuropsychopharmacol; 2008 Sep; 11(6):845-50. PubMed ID: 18405415
[TBL] [Abstract][Full Text] [Related]
13. Enhanced cortical dopamine output and antipsychotic-like effects of raclopride by alpha2 adrenoceptor blockade.
Hertel P; Fagerquist MV; Svensson TH
Science; 1999 Oct; 286(5437):105-7. PubMed ID: 10506554
[TBL] [Abstract][Full Text] [Related]
14. Prediction of drug-induced catalepsy based on dopamine D1, D2, and muscarinic acetylcholine receptor occupancies.
Haraguchi K; Ito K; Kotaki H; Sawada Y; Iga T
Drug Metab Dispos; 1997 Jun; 25(6):675-84. PubMed ID: 9193868
[TBL] [Abstract][Full Text] [Related]
15. An animal model of extrapyramidal side effects induced by antipsychotic drugs: relationship with D2 dopamine receptor occupancy.
Crocker AD; Hemsley KM
Prog Neuropsychopharmacol Biol Psychiatry; 2001 Apr; 25(3):573-90. PubMed ID: 11370998
[TBL] [Abstract][Full Text] [Related]
16. Enhanced cortical dopamine output and antipsychotic-like effect of raclopride with adjunctive low-dose L-dopa.
Eltayb A; Wadenberg ML; Svensson TH
Biol Psychiatry; 2005 Aug; 58(4):337-43. PubMed ID: 16102547
[TBL] [Abstract][Full Text] [Related]
17. Contrasting loxapine to its isomer isoloxapine--the critical role of in vivo D2 blockade in determining atypicality.
Natesan S; Vanderspek S; Nobrega JN; McClelland RA; Kapur S
Schizophr Res; 2005 Sep; 77(2-3):189-99. PubMed ID: 15925489
[TBL] [Abstract][Full Text] [Related]
18. D2 receptor occupancy in conscious rat brain is not significantly distinguished with [3H]-MNPA, [3H]-(+)-PHNO, and [3H]-raclopride.
Peng T; Zysk J; Dorff P; Elmore CS; Ström P; Malmquist J; Ding M; Tuke D; Werkheiser J; Widzowski D; Mrzljak L; Maier D
Synapse; 2010 Aug; 64(8):624-33. PubMed ID: 20340171
[TBL] [Abstract][Full Text] [Related]
19. Anticholinergic drugs potentiate dopamine D1 but not D2 antagonists on a conditioned avoidance task in rats.
Iorio LC; Cohen M; Coffin VL
J Pharmacol Exp Ther; 1991 Jul; 258(1):118-23. PubMed ID: 1830098
[TBL] [Abstract][Full Text] [Related]
20. In vivo occupancy of dopamine D2 receptors by antipsychotic drugs and novel compounds in the mouse striatum and olfactory tubercles.
Assié MB; Dominguez H; Consul-Denjean N; Newman-Tancredi A
Naunyn Schmiedebergs Arch Pharmacol; 2006 Sep; 373(6):441-50. PubMed ID: 16947046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
